Abstract
Objectives
This study reports the surgical outcomes of evisceration with primary orbital implant placement in patients with endophthalmitis and analyses the association with implant exposure and extrusion.
Methods
A retrospective, multicentre, Chinese cohort study. Review of medical records and orbital images of patients who underwent evisceration with primary orbital implant placement between January 2005 and January 2021.
Results
Out of 79 patients who underwent orbital evisceration with primary orbital implant placement, 26 (26 eyes) of them (male = 13) suffered from endophthalmitis. The duration from endophthalmitis diagnosis (19 = exogenous, 7 = endogenous) to evisceration was 9 standard deviation ± 5 (range: 1–15) days. The follow-up was 70 ± 46 (24–180) months after operation. The orbital implant size was 17 ± 3 (14–20) mm, and silicone was the most used material (69%, 18/26 of patients). The most frequent post-operative complication was orbital implant exposure (42%, 11/26), followed by orbital implant extrusion (12% 3/26) and ptosis (8%, 2/26). Implant exposure or extrusion was more commonly associated with endophthalmitis in comparison to non-endophthalmitis patients that required evisceration and primary orbital implant placement (54% versus 17%, P < 0.05). Univariate analysis showed single scleral closure technique (100% versus 58%, P < 0.05) and endogenous endophthalmitis (50% versus 0%, P < 0.05) were associated with implant exposure or extrusion, and only endogenous endophthalmitis was significant with multivariate analysis (P < 0.05).
Conclusions
Primary implant placement during evisceration should be avoided in eyes with endophthalmitis especially in those with an endogenous source, and double scleral closure technique may be a better alternative for primary orbital implant placement in infected eyes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All relevant raw data will be freely available to any researcher wishing to use them for non-commercial purposes, without breaching participant confidentiality.
References
Soares IP, França VP. Evisceration and enucleation. Semin Ophthalmol. 2010;25:94–7.
Dada T, Ray M, Tandon R, Vajpayee RB. A study of the indications and changing trends of evisceration in north India. Clin Exp Ophthalmol. 2002;30:120–3.
Tsai YY, Tseng SH. Risk factors in endophthalmitis leading to evisceration or enucleation. Ophthalmic Surg Lasers. 2001;32:208–12.
Yousuf SJ, Jones LS, Kidwell ED Jr. Enucleation and evisceration: 20 years of experience. Orbit 2012;31:211–5.
Viswanathan P, Sagoo MS, Olver JM. UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol. 2007;91:616–9.
Shore JW, Dieckert JP, Levine MR. Delayed primary wound closure. Use to prevent implant extrusion following evisceration for endophthalmitis. Arch Ophthalmol. 1988;106:1303–8. 10
Walter WL. Update on enucleation and evisceration surgery. Ophthalmic Plast Reconstr Surg. 1985;1:243–52.
Holds JB, Anderson RL. Primary vs Delayed Implant in Evisceration. Arch Ophthalmol. 1989;107:952.
Tawfik HA, Budin H. Evisceration with primary implant placement in patients with endophthalmitis. Ophthalmology 2007;114:1100–3.
Chiu SJ, Tan JHY, Currie ZI. To implant or not to implant: emergency orbital eviscerations with primary orbital implants. Eye. 2021;35:3077–86.
Kim JM, Sung JY, Lim HB, Choi EJ, Lee SB. Risk Factors for Orbital Implant Extrusion after Evisceration. J Clin Med 2021;10:3329. Published 2021 Jul 28
Dresner SC, Karesh JW. Primary implant placement with evisceration in patients with endophthalmitis. Ophthalmology. 2000;107:1661–4; discussion 1664–5.
Relhan N, Forster RK, Flynn HW Jr. Endophthalmitis: Then and Now. Am J Ophthalmol. 2018;187:xx–xxvii.
Liu D. A comparison of implant extrusion rates and postoperative pain after evisceration with immediate or delayed implants and after enucleation with implants. Trans Am Ophthalmol Soc. 2005;103:568–91.
Jordan DR, Stoica B. Evisceration with implant placement posterior to posterior sclera. Ophthalmic Plast Reconstr Surg. 2016;32:178–82.
Curragh DS, Kamalarajah S, Lacey B, White ST, McNab AA, Kalantzis G, et al. Primary replacement for the management of exposed orbital implant. Orbit 2019;38:461–7.
McElnea EM, Ryan A, Fulcher T. Porous orbital implant exposure: The influence of surgical technique. Orbit. 2014;33:104–8.
Nunery WR, Heinz GW, Bonnin JM, Martin RT, Cepela MA. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: Histopathologic correlation and comparison with silicone sphere implants. Ophthalmic Plast Reconstr Surg. 1993;9:96–104.
Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19:227–34.
Sadiq MA, Hassan M, Agarwal A, Sarwar S, Toufeeq S, Soliman MK, et al. Endogenous endophthalmitis: Diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015;5:32.
Chee SP, Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol. 2001;12:464–70.
Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: An east Asian experience and reappraisal of severe ocular affliction. Ophthalmology 2000;107:1483–91.
Chen YJ, Kuo HK, Wu PC, Kuo ML, Tsai HH, Liu CC, et al. A 10-year comparison of endogenous endophthalmitis outcomes: an east Asian experience with Klebsiella pneumoniae infection. Retina 2004;24:383–90.
Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, Hsu WM. Endogenous Klebsiella endophthalmitis associated with pyogenic liver abscess. Ophthalmology 2007;114:876–80.
Bee YS, Lin MC, Sheu SJ, Ng JD. Elevated white blood cell count may predict risk of orbital implant exposure. Can J Ophthalmol. 2014;49:45–9.
Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg. 2004;20:274–80.
Jordan DR. Problems after evisceration surgery with porous orbital implants: Experience with 86 patients. Ophthalmic Plast Reconstr Surg. 2004;20:374–80.
Author information
Authors and Affiliations
Contributions
All authors were responsible for the design of this study, extracting and analyzing data, drafting the manuscript, revising the manuscript critically, creating 'Summary of findings’ tables, provided feedback on the study and updated reference lists.
Corresponding author
Ethics declarations
COMPETING INTERESTS
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Lai, K.K.H., Au, A.K.H., Kuk, A.K.T. et al. Surgical outcomes of orbital evisceration with primary orbital implant placement in patients with endophthalmitis. Eye 37, 1361–1364 (2023). https://doi.org/10.1038/s41433-022-02135-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-022-02135-x